User:Mr. Ibrahem/Raxibacumab

Raxibacumab is a medication used to treat and prevent inhaled anthrax. It is generally used together with antibiotics. It is given by gradual injection into a vein.

Common side effects include pain at the site of injection, headache, rash, itchiness, and sleepiness. Other side effects may include anaphylaxis. It is a monoclonal antibody that binds to a part of the Bacillus anthracis toxin.

Raxibacumab was approved for medical use in the United States in 2012. In Europe it was given orphan designation in 2014. In the United States it can be acquired from the Strategic National Stockpile.